Progression of prodromal motor and non-motor symptoms in the premotor phase study - 2-year follow-up data
| Autor: | L. Van Nueten, Maarten Timmers, Johannes Streffer, Daniela Berg, Kathrin Brockmann, Rezzak Yilmaz, Isabel Wurster, Eva Schaeffer, Katharina Gauss, Inga Liepelt-Scarfone, B. Brändle, Walter Maetzler |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Risk 0301 basic medicine medicine.medical_specialty Parkinson's disease Prodromal Symptoms Disease 03 medical and health sciences 0302 clinical medicine Rating scale Internal medicine Humans Medicine ddc:610 Aged business.industry Task force Disease progression Follow up studies Parkinson Disease Middle Aged medicine.disease 030104 developmental biology Neurology Healthy individuals Disease Progression Non motor Female Human medicine physiopathology [Parkinson Disease] Neurology (clinical) Symptom Assessment business diagnosis [Parkinson Disease] 030217 neurology & neurosurgery Follow-Up Studies |
| Zdroj: | European journal of neurology 24(11), 1369-1374 (2017). doi:10.1111/ene.13397 European journal of neurology |
| ISSN: | 1351-5101 |
| DOI: | 10.1111/ene.13397 |
| Popis: | Background and purposeThe neuropathological process starts years before the diagnosis of Parkinson's disease (PD). Assessment of prodromal features in healthy individuals may help to define those with high risk for future PD. Our aim was to evaluate the presence and progression of prodromal markers in individuals with low risk [healthy controls (HC), n = 14] and high risk for PD (HR-PD, n = 34) and early PD (n = 14) patients. MethodsSeveral risk or prodromal markers were combined to define HR-PD. Other prodromal markers were followed in 6-month intervals for 2 years. As recommended by the Movement Disorder Society Task Force, likelihood ratios (LRs) of markers, motor scores and PD probability scores were calculated and compared. ResultsThe baseline LR for non-motor prodromal markers was significantly higher in PD and HR-PD compared to HC. Within 2 years, changes in these LRs did not significantly differ between the groups. Motor worsening was significant only in the PD group (50% of the patients) against HR-PD (15%) and HC (7%). Change in the non-motor prodromal LR did not significantly correlate with motor worsening, but higher baseline non-motor LRs were associated with Unified Parkinson's Disease Rating Scale III values at 2 years of follow-up. ConclusionsOur study shows that the frequency of non-motor prodromal markers is higher in the HR-PD group but does not increase within 2 years. The progression of motor and non-motor markers seems to be independent, but higher baseline non-motor burden is associated with the motor status after 2 years. Moreover, our data argue for a high impact of motor markers in the risk estimation for future PD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text